Humana Inc vs Innovative Industrial Properties Inc — how do they compare? Humana Inc trades at $436.1 (market cap $46.49B), while Innovative Industrial Properties Inc trades at $51.85 (market cap $1.43B). The key difference: Humana Inc is far larger — about 32.5× Innovative Industrial Properties Inc's market cap, and Innovative Industrial Properties Inc pays the higher dividend (14.64%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Innovative Industrial Properties Inc for 86 Days on average.
| HUM | IIPR | |
|---|---|---|
Market Cap | $46.49B | $1.43B |
Volume | 2,567,704 | 394,222 |
Sector | Health | Real Estate |
52-Week High | $409.85 | $64.67 |
52-Week Low | $163.67 | $44.58 |
Typical Hold Time | 53 Days | 86 Days |
Enterprise Value | $53.84B | $1.96B |
Dividend Yield | 0.91% | 14.64% |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $441.74, up 11.41% over 24 hours, reflecting strong momentum. The stock shows bullish technical signals with support at $391 and resistance at $406. Fundamentally, revenue grew to $129.66B in 2025, though net income margin compressed to 0.88%. Recent news highlights a Barclays upgrade to a $515 price target and upcoming Q3 earnings on November 6, 2026.
The outlook is cautiously optimistic with a consensus price target of $457.05 implying modest upside. Risks include margin pressure from Medicare Advantage plan changes and potential regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes.
IIPR trades at $52.36, up 2.21% today, with a bearish technical signal but oversold RSI readings. The company reported a Q2 2026 EPS beat of $1.36 versus $1.02 expected, though revenue declined to $266M in 2025. Valuation metrics appear attractive with a P/E of 11.75 and P/B of 0.83, while a recent $245 million mezzanine loan commitment signals active capital deployment.
The outlook balances a high dividend yield near 13% against tenant default risks and declining operating cash flow. Analyst consensus is mixed with a $84.67 price target, but the stock faces headwinds from sector volatility and earnings inconsistency, requiring careful risk assessment for income-focused investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
Read more on IIPR →